Ama-fatty acids ama-omega-3 ayingxenye yamafutha we-polyunsaturated, noma amafutha "amahle", afaka i-docosahexaenoic acid (i-DHA), i-alpha-linolenic acid (ALA), ne-eicosapentaenoic acid (EPA). Izifundo kubantu abanamazinga aphezulu e-triglyceride baye babonisa ukuthi ukuthatha noma yikuphi phakathi kwama-2 no-4 amagremu amafutha e-omega-3 angakwazi ukunciphisa amazinga we- triglyceride ngamaphesenti ama-50%.
Nakuba zitholakala ekudleni - njengezinhlanzi ezithile ezinamafutha namantongomane - amafutha om-omega-3 nawo atholakalayo ngamanani aphezulu ezincelweni ezihlukahlukene ezingatholakala kumashalofu esitolo. Ukwengeza, kukhona nemithi emithi kadokotela eline-omega-3 fatty acids, kuhlanganise no- Lovaza , Vascepa , ne-Epanova.
Ngayo yonke lezi zinqumo, ingathatha ama-add-counter-supplements aneziqu zama-omega-3 afaneleke nje ukuthola imithi yabo?
Izithako nemigomo equkethe ama-omega-3 fatty acids akuzona zonke ezidalwa ezilinganayo. Bobabili bahlangabezana nezimfuneko zokuqapha ezahlukene ezibekwa yi-Food and Drug Administration (FDA). Imikhiqizo engaphezulu, njenge-omega-3 fatty acid supplements etholakala ezitolo, ihlukaniswa ngokuthi "ukudla" yi-FDA. Lokhu kusho ukuthi ngumthwalo wemfanelo womkhiqizi ukuqinisekisa ukuthi izithako ziphephile, zingcolile, zibhalwe ngendlela efanele futhi zenziwe endaweni ephephile nehlanzekile.
Indlela kuphela i-FDA izosusa isamba esivela emakethe uma ngabe kube nezikhalazo eziningi zezempilo mayelana nomkhiqizo ngemuva kokuba sezifinyelele emashalofini esitolo.
Ngakolunye uhlangothi, izidakamizwa zemithi, zibhekwa kancane kancane. Ukuze kuvunyelwe ukusetshenziswa njengemithi yokwelashwa, imithi equkethe ama-omega-3 fatty acids kufanele ihlolwe kabanzi ngaphambi kokuba ibekelelwe ngabahlinzeki bezempilo futhi ithengiswe kuma-pharmacy.
Abakhiqizi kumele baqinisekise i-FDA ukuthi izidakamizwa zisebenza ukuthi kufanele ziphi, ukuthi ziphephile, nokuthi izidakamizwa ziqukethe zonke izithako ezishiwo kule ilebula. Kumele futhi adalule noma yikuphi ukulimala okuhlangenwe nakho kwabantu abathatha imithi.
Omunye umehluko phakathi kwalezi zinhlobo ezimbili zemikhiqizo yilezi zinhlayiyana ze-omega-3 fatty ziqukethe. Imithi ye-prescription efana ne-Lovaza ingaqukatha ama-acids angu-90% omega-3 ama-fatty kanti izithako ezingaphezu kwe-counter-container ziqukethe cishe ama-acids angu-30 no-50% we-omega-3 fatty acids, kuye ngomkhiqizo. Ngenkathi izithako ze-omega-3 zitholakala emphakathini jikelele, ama-omega-3 fatty acids kadokotela ajwayelekile aboniswa ukuba asetshenziswe kubantu abanamazinga aphakeme kakhulu e-triglyceride.
Ngenxa yokuthi ama-omega-3 fatty acid supplements akudingeki ukuba afinyelele ezidingweni zokuhlola eziningi ezenziwe ngama-omega-3 fatty acids, ngokuvamile zibiza kakhulu. Uma kuthathwa inani elilinganayo, ama-omega-3 fatty acids kanye nama-fatty acids ngaphezu kwe-counter-the-counter ama-fatty acid supplements kufanele anciphise i-triglycerides ngendlela efanayo.
Uma ucabangela ukwengeza izithako ze-omega-3 ekuqondiseni i-lipid-downing regimen, kufanele uthintane nomhlinzeki wakho wezempilo.
Ngisho noma zitholakala kalula, zingabangela imiphumela emibi futhi zikhulise izimo ezithile zezokwelapha.
> Imithombo:
> Ukuvunyelwa Kwemithi Yonke Imithi. Imibiko ye-FDC. Chevy Chase, MD 2005; 10 (2): 34.
> Dipiro JT, Talbert RL. I-Pharmacotherapy: Indlela Yokuthola Pathophysiological, 9th 2014.